Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Longevity

Inflammaging: Why Chronic Low-Grade Inflammation Drives Aging

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original language

In 2000, Claudio Franceschi and colleagues published a paper introducing the concept of inflammaging — the observation that chronic, low-grade, sterile inflammation is a hallmark of aging and a primary driver of most age-related diseases. Two decades of subsequent research have built one of the strongest mechanistic cases in geroscience. In the year 2000, Claudio Franceschi and colleagues at the University of Bologna published a paper in the journal Mechanisms of Ageing and Development that introduced a framework that has since become one of the most cited conceptual models in geroscience. The concept was inflammaging — a portmanteau combining inflammation and aging, pronounced as a single word. The central hypothesis was this: aging is characterized by a chronic, low-grade, sterile, systemic inflammatory state, and this state is not merely a byproduct of aging but an active driver of the diseases and functional declines that --- Paper cited: Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans Authors: Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G Journal: Mechanisms of Ageing and Development Year: 2000 DOI: 10.1016/S0047-6374(00)00243-3 --- Subscribe for one peer-reviewed paper made practical, every Tuesday and Friday. Free guide: How to Read Your Biomarker Panel at 55+ - {{LEAD_MAGNET_URL}} --- EDUCATIONAL CONTENT - NOT MEDICAL ADVICE This video is for general educational and informational purposes only. It summarizes peer-reviewed research. It does NOT constitute: - Medical advice, diagnosis, or treatment - Recommendations to start, stop, or change any medication - Dosing instructions for supplements or interventions - A substitute for consultation with a licensed physician Before applying anything discussed: - Talk to your physician, especially if you take prescription medications (statins, metformin, blood thinners, antihypertensives, GLP-1 agonists, etc.) - Discuss interactions, contraindications, and your individual risk profile - Get baseline biomarkers before changing your regimen if relevant Specific cautions: - Intermittent fasting: not appropriate for people with diabetes (especially Type 1), history of eating disorders, pregnancy, or underweight status without medical supervision. - Strength/Zone-2 training: medical clearance recommended for cardiovascular or joint conditions before initiating new training loads. - Supplements: third-party tested products preferred; verify drug interactions. AFFILIATE DISCLOSURE (FTC compliant): Some links in the description may be affiliate links. We may earn a commission at no additional cost to you. We only feature products and tools relevant to the research discussed. AI-ASSISTED PRODUCTION: Voice narration is generated via Edge TTS (Microsoft Neural Voice). Research, scriptwriting, and review are conducted by a human editor before publication. Reviewed: 2026-08-27

Longevity · 11 min · Source published: 2026-08-27

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…